RU2005140097A - Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний - Google Patents
Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний Download PDFInfo
- Publication number
- RU2005140097A RU2005140097A RU2005140097/15A RU2005140097A RU2005140097A RU 2005140097 A RU2005140097 A RU 2005140097A RU 2005140097/15 A RU2005140097/15 A RU 2005140097/15A RU 2005140097 A RU2005140097 A RU 2005140097A RU 2005140097 A RU2005140097 A RU 2005140097A
- Authority
- RU
- Russia
- Prior art keywords
- surfactants
- polydimethylsiloxane
- microns
- amphoteric
- proportion
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims 3
- 201000011510 cancer Diseases 0.000 title claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims 11
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 9
- -1 polydimethylsiloxane Polymers 0.000 claims 9
- 239000004094 surface-active agent Substances 0.000 claims 9
- 239000002280 amphoteric surfactant Substances 0.000 claims 6
- 239000003945 anionic surfactant Substances 0.000 claims 6
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 239000002736 nonionic surfactant Substances 0.000 claims 6
- 229910000323 aluminium silicate Inorganic materials 0.000 claims 4
- 239000010459 dolomite Substances 0.000 claims 4
- 229910000514 dolomite Inorganic materials 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 4
- 125000000129 anionic group Chemical group 0.000 claims 3
- 229910021536 Zeolite Inorganic materials 0.000 claims 2
- 239000012467 final product Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000010457 zeolite Substances 0.000 claims 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10323758.5 | 2003-05-22 | ||
| DE10323758A DE10323758A1 (de) | 2003-05-22 | 2003-05-22 | Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2005140097A true RU2005140097A (ru) | 2006-08-10 |
Family
ID=33441299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005140097/15A RU2005140097A (ru) | 2003-05-22 | 2004-05-19 | Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070172435A1 (https=) |
| EP (1) | EP1635849A1 (https=) |
| JP (1) | JP2006528211A (https=) |
| CN (1) | CN1795001A (https=) |
| AU (1) | AU2004243524A1 (https=) |
| CA (1) | CA2526175A1 (https=) |
| DE (1) | DE10323758A1 (https=) |
| RU (1) | RU2005140097A (https=) |
| WO (1) | WO2004105776A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10323759A1 (de) * | 2003-05-22 | 2004-12-16 | Bauer, Wulf, Dr. | Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen |
| DE102007043748A1 (de) | 2007-09-13 | 2008-09-11 | Basf Se | Verfahren zur kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat |
| DE102007043759A1 (de) | 2007-09-13 | 2008-09-11 | Basf Se | Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat |
| BE1018537A3 (fr) | 2007-09-13 | 2011-03-01 | Basf Se | Procede d'exploitation d'une separation en continu d'un produit cible x sous la forme d'un cristallisat finement divise. |
| DE102007043758A1 (de) | 2007-09-13 | 2008-10-23 | Basf Se | Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat des Zielproduktes X |
| DE102009045767A1 (de) | 2009-10-16 | 2010-08-12 | Basf Se | Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge |
| DE102010030279A1 (de) | 2010-06-18 | 2010-10-28 | Basf Se | Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge |
| US8461383B2 (en) | 2009-10-16 | 2013-06-11 | Basf Se | Process for starting up a separating process for purifying removal of acrylic acid crystals from a suspension S of crystals thereof in mother liquor |
| EP3223828B1 (en) * | 2014-11-24 | 2020-06-17 | University Of Technology, Sydney | Methods for the treatment and prevention of asbestos-related diseases |
| CN104606261B (zh) * | 2015-03-05 | 2018-02-09 | 潘友长 | 一种沸石药物组合物及其制备方法和用途 |
| CN105837734A (zh) * | 2016-05-09 | 2016-08-10 | 上海惠昌化工厂 | 有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
| US5418220A (en) * | 1994-03-08 | 1995-05-23 | Schmidt; Alfred | Method for treating constipation using dimethicone |
| US5587149A (en) * | 1995-02-06 | 1996-12-24 | R.P. Scherer Corporation | Topical application emulsions |
| DE19780248D2 (de) * | 1996-03-25 | 1999-03-11 | Bauer Wulf Dr | Heilmittel zur äußerlichen Anwendung und Verwendung einer wässrigen Öl-Emulsion für ein derartiges Heilmittel |
| US6347408B1 (en) * | 1998-11-05 | 2002-02-19 | Allegiance Corporation | Powder-free gloves having a coating containing cross-linked polyurethane and silicone and method of making the same |
| EP1316530B1 (de) * | 1999-04-26 | 2004-12-15 | Tihomir Lelas | Mikronisierte Zoelithe zur Verwendung als pharmazeutisches Mittel |
-
2003
- 2003-05-22 DE DE10323758A patent/DE10323758A1/de not_active Withdrawn
-
2004
- 2004-05-19 WO PCT/DE2004/001048 patent/WO2004105776A1/de not_active Ceased
- 2004-05-19 JP JP2006529603A patent/JP2006528211A/ja not_active Withdrawn
- 2004-05-19 RU RU2005140097/15A patent/RU2005140097A/ru unknown
- 2004-05-19 EP EP04733761A patent/EP1635849A1/de not_active Withdrawn
- 2004-05-19 CN CNA2004800140406A patent/CN1795001A/zh active Pending
- 2004-05-19 AU AU2004243524A patent/AU2004243524A1/en not_active Abandoned
- 2004-05-19 CA CA002526175A patent/CA2526175A1/en not_active Abandoned
- 2004-05-19 US US10/557,317 patent/US20070172435A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1795001A (zh) | 2006-06-28 |
| JP2006528211A (ja) | 2006-12-14 |
| CA2526175A1 (en) | 2004-12-09 |
| DE10323758A1 (de) | 2004-12-16 |
| WO2004105776A1 (de) | 2004-12-09 |
| EP1635849A1 (de) | 2006-03-22 |
| AU2004243524A1 (en) | 2004-12-09 |
| US20070172435A1 (en) | 2007-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
| WO2007054279A3 (en) | Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions | |
| EP2182006A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| MXPA05008368A (es) | 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana. | |
| NZ602557A (en) | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
| IL207468A (en) | HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections | |
| EP2213684A3 (en) | Nogo-a antibodies for the treatment of Alzheimer disease | |
| TW200716631A (en) | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof | |
| SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| RU2005140097A (ru) | Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний | |
| WO2007100366A3 (en) | Quinolone m1 receptor positive allosteric modulators | |
| NO20074536L (no) | Anvendelse av jern (III)-komplekssammensetninger | |
| WO2007041487A3 (en) | Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family | |
| EP1423137A4 (en) | Lipopeptide stereoisomers, methods for preparing same, and useful intermediates | |
| TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| EA201791138A1 (ru) | Фармацевтическая композиция, ее приготовление и применения | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| EA200801411A1 (ru) | Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях | |
| WO2009151498A3 (en) | Memantine formulations | |
| HK1079984A1 (zh) | 抑制hiv复制的甘氨酰胺衍生物 | |
| MXPA01008613A (es) | Epitopos o mimotopos derivados del dominio c-epsilon-2 de ige, antagonistas de los mismos y sus usos terapeuticos. | |
| WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
| GB0123276D0 (en) | Uses of agents that bind immune-system components | |
| IT1317905B1 (it) | Varianti di allergeni ns-ltps, loro usi e composizioni che lecomprendono. | |
| MXPA05007495A (es) | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. |